PMI-005

N/A

Report date: 2024/01/19 15:04:16

NME

Base Information

Drug NamePMI-005

Drug Alias NamePMI-005

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionCyclooxygenase-2 inhibitorsNitric oxide synthase, inducible inhibitorsInterleukin-1 alpha inhibitors +[4]

TargetsCyclooxygenase-2Nitric oxide synthase, inducibleInterleukin-1 alpha +[4]

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPhytomedics Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPhytomedics Inc

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A